NO20003051D0 - Metode for administrering av AspB28-humant insulin - Google Patents

Metode for administrering av AspB28-humant insulin

Info

Publication number: NO20003051D0
Authority: NO; Norway
Prior art keywords: administration; human insulin; aspb28 human; aspb28; insulin
Prior art date: 1998-01-08

Application number

NO20003051A

Other languages

English (en)

Norwegian (no)

Other versions

NO20003051L (no

Inventor

Richard Dennis Dimarchi

Roger Garrick Harrison

Ronald Keith Wolff

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-08

Filing date

2000-06-14

Publication date

2000-06-14

2000-06-14 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2000-06-14 Publication of NO20003051L publication Critical patent/NO20003051L/no

2000-06-14 Publication of NO20003051D0 publication Critical patent/NO20003051D0/no

Links

101000976075 Homo sapiens Insulin Proteins 0.000 title 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Immunology (AREA)
Zoology (AREA)
Obesity (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

NO20003051A 1998-01-08 2000-06-14 Metode for administrering av AspB28-humant insulin NO20003051D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7075298P	1998-01-08	1998-01-08
PCT/US1999/000290 WO1999034815A1 (en)	1998-01-08	1999-01-07	Method for administering aspb28-human insulin

Publications (2)

Publication Number	Publication Date
NO20003051L NO20003051L (no)	2000-06-14
NO20003051D0 true NO20003051D0 (no)	2000-06-14

Family

ID=22097181

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20003051A NO20003051D0 (no)	1998-01-08	2000-06-14	Metode for administrering av AspB28-humant insulin
NO20003050A NO20003050L (no)	1998-01-08	2000-06-14	Metode for Õ administrere monomere insulinanaloger

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20003050A NO20003050L (no)	1998-01-08	2000-06-14	Metode for Õ administrere monomere insulinanaloger

Country Status (16)

Country	Link
US (2)	US20010007853A1 (de)
EP (2)	EP0951911A3 (de)
JP (2)	JP2002500193A (de)
KR (2)	KR20010033940A (de)
CN (2)	CN1195543C (de)
AU (2)	AU754707B2 (de)
BR (2)	BR9906813A (de)
CA (2)	CA2317733A1 (de)
EA (2)	EA200000748A1 (de)
HU (2)	HUP0100391A3 (de)
IL (2)	IL137105A0 (de)
NO (2)	NO20003051D0 (de)
PL (2)	PL342745A1 (de)
TR (2)	TR200001892T2 (de)
WO (2)	WO1999034816A1 (de)
ZA (2)	ZA99104B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6131567A (en) *	1993-01-29	2000-10-17	Aradigm Corporation	Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US20060171899A1 (en) *	1998-12-10	2006-08-03	Akwete Adjei	Water-stabilized aerosol formulation system and method of making
US6858199B1 (en) *	2000-06-09	2005-02-22	Advanced Inhalation Research, Inc.	High efficient delivery of a large therapeutic mass aerosol
EP1196445A1 (de) *	1999-06-29	2002-04-17	Eli Lilly And Company	Insulinkristalle zur verabreichung über die lunge
US6458387B1 (en) *	1999-10-18	2002-10-01	Epic Therapeutics, Inc.	Sustained release microspheres
ATE430558T1 (de)	2000-10-27	2009-05-15	Baxter Healthcare Sa	Herstellung von mikrokügelchen
US20030064033A1 (en) *	2001-08-16	2003-04-03	Brown Larry R.	Propellant-based microparticle formulations
EP1944016A1 (de)	2001-08-16	2008-07-16	Baxter International Inc.	Mikropartikelformulierungen auf Treibgasbasis
CA2466525C (en) *	2001-12-07	2011-05-17	Eiffel Technologies Limited	Synthesis of small particles
AU2002359730A1 (en) *	2001-12-21	2003-07-30	Smithkline Beecham Corporation	Compositions and methods for altering glucose production
US6985798B2 (en) *	2002-05-10	2006-01-10	Oriel Therapeutics, Inc.	Dry powder dose filling systems and related methods
US7118010B2 (en)	2002-05-10	2006-10-10	Oriel Therapeutics, Inc.	Apparatus, systems and related methods for dispensing and /or evaluating dry powders
US6889690B2 (en)	2002-05-10	2005-05-10	Oriel Therapeutics, Inc.	Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7677411B2 (en) *	2002-05-10	2010-03-16	Oriel Therapeutics, Inc.	Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
AU2003251760A1 (en)	2002-06-27	2004-01-19	Oriel Therapeutics, Inc.	Apparatus and methods for dispensing dry powders
US7377277B2 (en)	2003-10-27	2008-05-27	Oriel Therapeutics, Inc.	Blister packages with frames and associated methods of fabricating dry powder drug containment systems
WO2005044173A1 (en)	2003-10-27	2005-05-19	Oriel Therapeutics, Inc.	Blister packages and associated methods of fabricating dry powder drug containment systems
US7451761B2 (en) *	2003-10-27	2008-11-18	Oriel Therapeutics, Inc.	Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
WO2005065756A2 (en)	2003-12-30	2005-07-21	Oriel Therapeutics, Inc.	Dry powder nebulizers and associated methods of dispensing dry powders
US7624733B2 (en)	2004-02-09	2009-12-01	Oriel Therapeutics, Inc.	Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
WO2006031775A2 (en)	2004-09-13	2006-03-23	Oriel Therapeutics, Inc.	Dry powder inhalers that inhibit agglomeration, related devices and methods
AU2006283113B2 (en) *	2005-08-25	2011-12-01	Oriel Therapeutics, Inc.	Drug containment systems with sticks, related kits, dry powder inhalers and methods
US7987845B2 (en) *	2006-01-31	2011-08-02	Oriel Therapeutics, Inc.	Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP2060268A1 (de) *	2007-11-15	2009-05-20	Novo Nordisk A/S	Pharmazeutische Zusammensetzungen für die Zufuhr von Peptiden über die Lunge oder Nase
WO2010036839A2 (en)	2008-09-26	2010-04-01	Oriel Therapeutics, Inc.	Inhalers with airway disks having discrete airway channels and related disks and methods
US8887722B2 (en) *	2008-09-26	2014-11-18	Oriel Therapeutics, Inc.	Inhaler mechanisms with radially biased piercers and related methods
MX2011003233A (es) *	2008-09-26	2011-04-28	Oriel Therapeutics Inc	Inhaladores de polvo seco con miembros de perforacion doble y dispositivos y metodos relacionados.
US8991391B2 (en) *	2008-09-30	2015-03-31	Oriel Therapeutics, Inc.	Dry powder inhalers with endless strips and cooperating piercers and related methods
US9050427B2 (en) *	2008-09-30	2015-06-09	Oriel Therapeutics, Inc.	Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
WO2010039202A2 (en) *	2008-10-01	2010-04-08	Oriel Therapeutics, Inc.	Dry powder inhalers with rotating piercing mechanisms and related devices and methods
JP5341532B2 (ja) *	2009-01-19	2013-11-13	第一電子工業株式会社	１対の誤嵌合防止キー及び該キーを用いた電気コネクタ
CN101912600B (zh) *	2010-01-11	2014-01-29	杨国汉	改善胰岛素在溶液中稳定性的方法
EP2362796A4 (de)	2010-01-27	2014-10-08	Aespira Ltd	Trockenpulverinhalator
USD641076S1 (en)	2010-03-26	2011-07-05	Oriel Therapeutics, Inc.	Dry powder inhaler
USD635246S1 (en)	2010-03-26	2011-03-29	Oriel Therapeutics, Inc.	Dose disk for dry powder inhalers
US10238820B2 (en)	2014-01-08	2019-03-26	Seroton, Inc.	Dry-powder inhalation device
US11491288B2 (en)	2014-01-08	2022-11-08	Seroton, Inc.	Dispenser for dry-powder inhalation devices
WO2024100652A1 (en)	2022-11-07	2024-05-16	Kritzman Kadron Amnon	High performance dry powder inhaler

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK179286D0 (da) *	1986-04-18	1986-04-18	Nordisk Gentofte	Insulinpraeparat
IL93282A (en) *	1989-02-09	1995-08-31	Lilly Co Eli	Insulin analogues
US5230884A (en) *	1990-09-11	1993-07-27	University Of Wales College Of Cardiff	Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US6131567A (en) *	1993-01-29	2000-10-17	Aradigm Corporation	Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
JP2837956B2 (ja) *	1993-06-21	1998-12-16	ノボノルディスクアクティーゼルスカブ	Ａｓｐ▲上Ｂ２８▼インスリン結晶
DK72793D0 (da) *	1993-06-21	1993-06-21	Novo Nordisk As	Nyt produkt
TW402506B (en) *	1993-06-24	2000-08-21	Astra Ab	Therapeutic preparation for inhalation
US5451569A (en) *	1994-04-19	1995-09-19	Hong Kong University Of Science And Technology R & D Corporation Limited	Pulmonary drug delivery system
US5461031A (en) *	1994-06-16	1995-10-24	Eli Lilly And Company	Monomeric insulin analog formulations
US5547929A (en) *	1994-09-12	1996-08-20	Eli Lilly And Company	Insulin analog formulations
YU18596A (sh) *	1995-03-31	1998-07-10	Eli Lilly And Company	Analogne formulacije monomernog insulina
EP0741188A3 (de) *	1995-05-05	1999-07-14	Eli Lilly And Company	Einkettiges Insulin mit erhöhter Biowirkung

1999
- 1999-01-06 US US09/226,420 patent/US20010007853A1/en not_active Abandoned
- 1999-01-06 US US09/226,412 patent/US20010053761A1/en not_active Abandoned
- 1999-01-07 EA EA200000748A patent/EA200000748A1/ru unknown
- 1999-01-07 HU HU0100391A patent/HUP0100391A3/hu unknown
- 1999-01-07 BR BR9906813-3A patent/BR9906813A/pt not_active IP Right Cessation
- 1999-01-07 EP EP99300122A patent/EP0951911A3/de not_active Withdrawn
- 1999-01-07 ZA ZA9900104A patent/ZA99104B/xx unknown
- 1999-01-07 KR KR1020007007524A patent/KR20010033940A/ko not_active Withdrawn
- 1999-01-07 CA CA002317733A patent/CA2317733A1/en not_active Abandoned
- 1999-01-07 AU AU21073/99A patent/AU754707B2/en not_active Ceased
- 1999-01-07 JP JP2000527264A patent/JP2002500193A/ja not_active Withdrawn
- 1999-01-07 ZA ZA9900105A patent/ZA99105B/xx unknown
- 1999-01-07 TR TR2000/01892T patent/TR200001892T2/xx unknown
- 1999-01-07 TR TR2000/01891T patent/TR200001891T2/xx unknown
- 1999-01-07 PL PL99342745A patent/PL342745A1/xx not_active Application Discontinuation
- 1999-01-07 CA CA002317739A patent/CA2317739A1/en not_active Abandoned
- 1999-01-07 CN CNB998020192A patent/CN1195543C/zh not_active Expired - Fee Related
- 1999-01-07 PL PL99341592A patent/PL341592A1/xx not_active Application Discontinuation
- 1999-01-07 IL IL13710599A patent/IL137105A0/xx unknown
- 1999-01-07 WO PCT/US1999/000324 patent/WO1999034816A1/en not_active Ceased
- 1999-01-07 KR KR1020007007525A patent/KR20010033941A/ko not_active Withdrawn
- 1999-01-07 EP EP99300111A patent/EP0951910A3/de not_active Withdrawn
- 1999-01-07 JP JP2000527263A patent/JP2002500192A/ja not_active Withdrawn
- 1999-01-07 WO PCT/US1999/000290 patent/WO1999034815A1/en not_active Ceased
- 1999-01-07 BR BR9906796-0A patent/BR9906796A/pt not_active Application Discontinuation
- 1999-01-07 EA EA200000747A patent/EA200000747A1/ru unknown
- 1999-01-07 AU AU23122/99A patent/AU747619B2/en not_active Ceased
- 1999-01-07 HU HU0101293A patent/HUP0101293A3/hu unknown
- 1999-01-07 CN CN99802020A patent/CN1287492A/zh active Pending
- 1999-01-07 IL IL13715099A patent/IL137150A0/xx unknown
2000
- 2000-06-14 NO NO20003051A patent/NO20003051D0/no not_active Application Discontinuation
- 2000-06-14 NO NO20003050A patent/NO20003050L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TR200001891T2 (tr)	2000-11-21
CA2317733A1 (en)	1999-07-15
ZA99105B (en)	2000-07-07
IL137150A0 (en)	2001-07-24
HUP0100391A3 (en)	2001-12-28
EP0951911A3 (de)	2002-06-19
NO20003051L (no)	2000-06-14
NO20003050D0 (no)	2000-06-14
HUP0100391A2 (hu)	2001-08-28
BR9906796A (pt)	2000-11-14
AU2312299A (en)	1999-07-26
JP2002500192A (ja)	2002-01-08
KR20010033941A (ko)	2001-04-25
AU754707B2 (en)	2002-11-21
HUP0101293A2 (hu)	2001-08-28
EA200000748A1 (ru)	2000-12-25
BR9906813A (pt)	2001-03-20
AU2107399A (en)	1999-07-26
TR200001892T2 (tr)	2000-11-21
JP2002500193A (ja)	2002-01-08
EP0951910A2 (de)	1999-10-27
PL342745A1 (en)	2001-07-02
WO1999034815A1 (en)	1999-07-15
EA200000747A1 (ru)	2000-12-25
NO20003050L (no)	2000-06-14
WO1999034816A1 (en)	1999-07-15
HUP0101293A3 (en)	2001-12-28
US20010007853A1 (en)	2001-07-12
AU747619B2 (en)	2002-05-16
KR20010033940A (ko)	2001-04-25
PL341592A1 (en)	2001-04-23
CA2317739A1 (en)	1999-07-15
IL137105A0 (en)	2001-06-14
US20010053761A1 (en)	2001-12-20
EP0951911A2 (de)	1999-10-27
EP0951910A3 (de)	2002-06-19
CN1287492A (zh)	2001-03-14
CN1287491A (zh)	2001-03-14
ZA99104B (en)	2000-07-07
CN1195543C (zh)	2005-04-06

Legal Events

Date	Code	Title	Description
2002-10-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20003051D0 (no)	2000-06-14	Metode for administrering av AspB28-humant insulin
NO20006630L (no)	2001-02-26	Farmasöytisk sammensetning for behandlingen av diabetes
IS5245A (is)	1999-11-11	Lyfjablanda úr ómeprasól
IL147217A0 (en)	2002-11-10	New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
CY2007001I1 (el)	2009-11-04	Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DK1223997T3 (da)	2009-03-30	Medicinsk infusionssæt
DE60043305D1 (de)	2009-12-24	Pharmazeutische zubereitungen zur behandlung von insulinresitenz
FI972292A0 (fi)	1997-05-30	Administrering av diabetes
EE200100259A (et)	2002-12-16	Moksifloksatsiini farmatseutiline preparaat
NO994613D0 (no)	1999-09-23	Fremgangsmaate og preparat til behandling av sövn-apne
NO20005179D0 (no)	2000-10-13	Medikament behandling
NO20013958L (no)	2001-10-15	Legemiddel for behandling av höyt blodtrykk
NO20026212D0 (no)	2002-12-23	Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
ZA984268B (en)	1999-06-23	Method and composition for administering taxanes orally to human patients
NO20003229D0 (no)	2000-06-21	Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer
FI964619A7 (fi)	1996-11-19	Epilepsialääkkeiden iholle annostelu
HUP0300402A3 (en)	2005-07-28	Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
NO20014812D0 (no)	2001-10-03	Fremgangsmåte for tilveiebringelse av kosmetisk/medisinsk terapi
NO20020784L (no)	2002-02-18	Medikament for behandling av brudd
DE69832974D1 (de)	2006-02-02	Gerät zur intrakardialen verabreichung von medikamenten
IL155819A0 (en)	2003-12-23	Methods of treatment comprising administration of substance p
NO20022990L (no)	2002-08-20	Fremgangsmåte og sammensetning for behandling av smerte
NO20001895D0 (no)	2000-04-12	Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer
ID28817A (id)	2001-07-05	Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
AU2002328905A1 (en)	2003-03-03	A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method